Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 29, 2014	Jun. 30, 2013	Jul. 01, 2012
Operating activities:
Net income	$ 14,675	$ 12,321	$ 17,646
Operating activities of discontinued operations	1,587	(179)	1,435
Loss/(gain) on sale of discontinued operations	(1,300)	2,348	(8,683)
Depreciation and amortization	19,848	18,798	19,539
Amortization of deferred financing costs	306	420	457
Deferred income taxes	1,454	(811)	7,790
Bad debt expense	1,656	1,085	869
Stock-based compensation	4,664	4,283	4,850
Excess tax benefit from stock-based compensation	(1,837)	(739)	(273)
Other non-cash items	755	483	42
Changes in operating items, excluding the effects of acquisitions:
Receivables	(1,893)	(4,108)	(2,135)
Inventories	(2,564)	(1,823)	(3,919)
Prepaid and other	436	(1,655)	(2,126)
Accounts payable and accrued expenses	2,660	4,368	1,694
Other assets	(262)	(609)	1,646
Other liabilities	2,355	463	947
Net cash provided by operating activities	42,539	34,645	39,779
Investing activities:
Acquisitions, net of cash acquired	(9,000)	(3,700)	(4,336)
Proceeds from sale of business			12,823
Capital expenditures	(22,985)	(20,044)	(17,180)
Purchase of investments	8	(903)	(3,945)
Other, net	(11)	117	(119)
Investing activities of discontinued operations	500		(124)
Net cash used in investing activities	(31,488)	(24,530)	(12,881)
Financing activities:
Acquisition of treasury stock	(8,317)	(9,599)	(3,277)
Excess tax benefit from stock based compensation	1,837	739	273
Proceeds from exercise of employee stock options	527	535
Proceeds from bank borrowings	127,000	62,000	56,000
Repayment of notes payable and bank borrowings	(127,052)	(91,250)	(71,000)
Debt issuance cost		(1,234)
Repayment of capital lease obligations		(6)	(1,482)
Other	3
Net cash used in financing activities	(6,002)	(38,815)	(19,486)
Net change in cash and cash equivalents	5,049	(28,700)	7,412
Cash and cash equivalents:
Beginning of year	154	28,854	21,442
End of year	$ 5,203	$ 154	$ 28,854